Title: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.

Authors: Swneke D Bailey, Changchun Xie, Ron Do, Alexandre Montpetit, Rafael Diaz, Viswanathan Mohan, Bernard Keavney, Salim Yusuf, Hertzel C Gerstein, James C Engert, Sonia Anand,

Journal, date & volume: Diabetes Care, 2010 Oct , 33, 2250-3

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/20628086

Abstract